Breaking this cycle requires understanding both sides, the anxiety driving use, and the substance use driving anxiety.
How Substances Temporarily Relieve Anxiety
Different substances manage anxiety through different mechanisms: alcohol enhances GABA (calming) and suppresses glutamate (excitatory), reducing anxiety quickly, benzodiazepines directly enhance GABA receptors, extremely effective at stopping panic, cannabis reduces hyperarousal for some people (though it induces anxiety in others, particularly at high doses), and opioids produce calm, emotional distance, and euphoria. All of these effects are real in the short term.
How Substances Make Anxiety Worse Long-Term
The same mechanisms that produce short-term relief create long-term worsening: alcohol, the brain compensates by reducing GABA and increasing glutamate, when alcohol wears off, the excitatory glutamate surge produces rebound anxiety worse than baseline. Benzos, rapid tolerance develops, the anxiety that returns between doses is more intense than before. This rebound cycle directly drives substance dependence in anxiety sufferers.
Social Anxiety and Alcohol: A Common Combination
Social anxiety disorder and alcohol use disorder are among the most common co-occurring conditions, alcohol's social lubricant effect provides genuine short-term social anxiety relief. Many people with social anxiety discover alcohol reduces their social fear, leading to alcohol-dependent socialization. Recovery requires learning to navigate social situations without alcohol, which often requires direct treatment of the underlying social anxiety.
Treating Anxiety Without Addictive Substances
Effective non-addictive anxiety treatments: CBT with exposure therapy, the gold standard for most anxiety disorders, addresses the underlying thought patterns and avoidance behaviors, SSRIs/SNRIs, first-line medication for anxiety disorders, non-addictive, buspirone, non-addictive anxiolytic, beta-blockers (propranolol), for situational anxiety (public speaking, performance), and mindfulness-based approaches. These approaches treat the anxiety rather than suppressing it.
Integrated Dual-Diagnosis Treatment for Anxiety and Addiction
Treating anxiety and addiction simultaneously is significantly more effective than sequential treatment. CBT adapted for dual diagnosis addresses both: exposure therapy for anxiety (reducing avoidance), and relapse prevention for addiction (reducing trigger-driven use). A psychiatrist familiar with addiction can prescribe appropriate non-addictive anxiety medications.
Anxiety in Early Recovery: The Rebound Effect
Anxiety is often significantly worse in early recovery, particularly from alcohol and benzodiazepines. The rebound anxiety of withdrawal can be more intense than the original anxiety that drove use. This is neurologically expected and temporary, but it's one of the primary drivers of relapse. Having non-addictive anxiety support in place before stopping substances dramatically improves early recovery success.
"Forge gave me the daily structure I needed. 8 months clean."
"The streak tracker keeps me honest. 14 months sober."
"SOS mode has saved me more times than I can count."
Start Your Recovery Today
Join 50,000+ people using Forge to track their progress and stay accountable.
Download Forge FreeFrequently Asked Questions
Does anxiety cause addiction?
Yes, anxiety disorders significantly increase addiction risk. People with untreated anxiety are more likely to use substances for self-medication. Social anxiety and alcohol use disorder co-occur at particularly high rates. Treating the underlying anxiety is essential for sustained addiction recovery.
Does addiction cause anxiety?
Yes, chronic substance use neurochemically induces anxiety through adaptation and rebound. Alcohol withdrawal produces severe anxiety, benzo withdrawal produces intense anxiety, stimulant withdrawal produces anxiety and depression. Substance-induced anxiety typically resolves with sustained abstinence.
What is the best treatment for anxiety and addiction?
Integrated dual-diagnosis treatment combining: CBT (particularly exposure-based CBT for anxiety disorders), SSRIs or SNRIs (non-addictive, first-line for anxiety), and addiction-specific treatment (therapy, peer support, MAT if indicated). Treating both conditions simultaneously is more effective than sequential treatment.
Is anxiety worse in early recovery?
Often yes, particularly for alcohol and benzodiazepine withdrawal, where rebound anxiety is intense. Anxiety typically improves significantly within weeks to months of sustained abstinence. Having non-addictive anxiety support (CBT, medication) in place before stopping significantly reduces this challenge.
What medications treat anxiety in recovery?
SSRIs (fluoxetine, sertraline, escitalopram) and SNRIs (venlafaxine, duloxetine) are first-line, non-addictive options. Buspirone is a non-addictive anxiolytic. Beta-blockers (propranolol) for situational anxiety. Avoid benzodiazepines in addiction recovery due to addiction potential.
Does CBD help with anxiety in recovery?
CBD has limited but emerging evidence for anxiety reduction. It's non-intoxicating and non-addictive. However, CBD products vary enormously in quality and dosage, and interactions with other medications are possible. Discuss with a physician before using CBD in recovery. It's not a substitute for evidence-based anxiety treatment.
What is panic disorder in addiction?
Panic disorder, recurrent unexpected panic attacks, co-occurs with addiction at high rates, particularly alcohol and benzodiazepine use disorder (which are often used to manage panic). CBT with interoceptive exposure (learning to tolerate panic sensations without substances) is highly effective for panic disorder in recovery.
Can you have anxiety without substances after long-term use?
Yes, people who used substances to manage anxiety for years often feel unable to manage anxiety without them early in recovery. This is real: the natural anxiety regulation systems have atrophied through disuse. CBT, SSRIs, and time rebuild these systems. Most people find their anxiety substantially better 3–6 months into recovery than during active use.
What is the relationship between anxiety and addiction?
Anxiety and addiction bidirectional relationship: anxiety disorders are among the most common co-occurring conditions with substance use disorders, approximately 20% of people with anxiety disorders have a co-occurring SUD, and approximately 20% of people with SUD have a co-occurring anxiety disorder. The relationship is bidirectional. Self-medication pathway: anxiety → substance use to manage anxiety symptoms → short-term relief → tolerance develops → withdrawal worsens anxiety → increased use. Substance-induced anxiety: many substances directly cause or worsen anxiety through neurochemical effects (alcohol rebound, cannabis-induced paranoia, stimulant-induced hyperarousal, withdrawal from any CNS depressant). Shared biology: both anxiety disorders and SUDs involve dysregulation of the HPA axis, amygdala hyperreactivity, and prefrontal cortex hypofunction, suggesting common neurobiological vulnerabilities.
Which comes first, anxiety or addiction?
Anxiety or addiction, which precedes the other: longitudinal studies suggest anxiety disorders typically precede substance use disorders in the majority of comorbid cases (approximately 60% of cases). The temporal primacy of anxiety supports the self-medication hypothesis. However: substances can also cause new-onset anxiety disorders through their neurochemical effects, not all comorbidity reflects self-medication. Assessment: a period of sustained abstinence (4-8 weeks minimum) is often needed to distinguish substance-induced anxiety from primary anxiety disorder. Anxiety that predates substance use, or that persists well into sustained abstinence, suggests primary anxiety disorder requiring independent treatment. Anxiety that emerges or escalates with substance use and significantly improves with sustained abstinence suggests a substance-induced or substance-exacerbated component.
What are the best treatments for co-occurring anxiety and addiction?
Treating anxiety and addiction together: integrated treatment, addressing both conditions simultaneously in the same treatment setting, produces significantly better outcomes than sequential treatment (treating one first). Evidence-based approaches: CBT is the most effective behavioral intervention for both anxiety disorders and SUDs, with significant overlap, the skills for managing anxiety (cognitive restructuring, exposure, coping skills) directly support addiction recovery. Medications: SSRIs and SNRIs are first-line for most anxiety disorders and are safe to use in addiction recovery (no abuse potential), naltrexone for AUD, buprenorphine for OUD. What to avoid: benzodiazepines for anxiety in people with SUD, high abuse potential, rapid tolerance development, and dangerous interactions. Finding integrated care: SAMHSA's National Helpline (1-800-662-4357) can refer to integrated dual diagnosis programs.
Can CBD or cannabis help with anxiety in recovery?
Cannabis and CBD for anxiety in recovery: a complex and contested area. CBD (cannabidiol without THC): early research suggests anxiolytic properties, no psychoactive component, no known abuse potential at therapeutic doses. However: research quality is limited, optimal doses are unclear, and products vary significantly in CBD content. In recovery from cannabis use disorder: CBD products that contain any THC can trigger relapse. For people in recovery from other substances: CBD may be worth discussing with a physician, but the evidence base is not yet robust enough for confident recommendation. THC-containing cannabis: cannabis is anxiolytic for some people acutely but is associated with increased anxiety, paranoia, and panic in many users, particularly with high-THC products. Not recommended for anxiety management in recovery. The bottom line: if anxiety is a significant issue in recovery, evidence-based interventions (CBT, SSRIs, exercise) have a stronger evidence base than cannabis or CBD.
How does alcohol affect anxiety?
Alcohol and anxiety, the mechanism: alcohol enhances GABA (inhibitory) and suppresses glutamate (excitatory), producing the initial anxiolytic (anxiety-reducing) effect that makes it appealing for social anxiety and situational stress. The rebound: 4-8 hours after drinking, GABA activity undershoots its pre-drinking level and glutamate surges, producing rebound anxiety more intense than the original level. The cycle: pre-existing anxiety → alcohol to manage it → temporary relief → rebound anxiety worse than before → increased alcohol use to manage increasingly severe anxiety. Long-term: chronic heavy drinking maintains the brain in a state of GABA/glutamate dysregulation with chronically elevated anxiety between drinks. After quitting: anxiety initially worsens (withdrawal), then improves substantially as the brain rebalances, typically reaching a lower baseline than during the drinking period at months 1-3.
What types of anxiety disorders are most common in addiction?
Anxiety disorders most commonly co-occurring with addiction: social anxiety disorder: the most common in alcohol use disorder, social anxiety drives drinking to facilitate social interaction, alcohol temporarily reduces the social inhibition but perpetuates the disorder. GAD (Generalized Anxiety Disorder): chronic worry comorbid with multiple SUDs, marijuana, alcohol, and benzodiazepines are commonly used to manage it. PTSD: trauma underlies a large proportion of SUD comorbidity, PTSD and substance use have particularly high co-occurrence, especially in military veterans and survivors of abuse. Panic disorder: alcohol and benzodiazepines are common self-medications, panic attacks during withdrawal worsen the cycle. OCD: less commonly co-occurring but documented, rituals and obsessions drive substance use for relief. Each anxiety disorder type has specific evidence-based treatments, the specific anxiety disorder should be identified and addressed, not just 'anxiety' generally.
How do I manage anxiety without substances?
Managing anxiety without substances: evidence-based approaches: CBT (Cognitive Behavioral Therapy): restructures catastrophic thinking patterns, builds cognitive and behavioral skills for anxiety management. Exposure therapy: for specific phobias and social anxiety, gradual exposure to anxiety-triggering stimuli reduces the conditioned anxiety response. Exercise: robust evidence for anxiety reduction, 30-60 minutes of aerobic exercise produces acute anxiolytic effects and builds long-term anxiety resilience. Mindfulness and meditation: reduces anxiety through both attention regulation and autonomic nervous system regulation. SSRIs/SNRIs: first-line medications for GAD, social anxiety, panic disorder. No abuse potential. Sleep hygiene: sleep deprivation dramatically amplifies anxiety, improving sleep is a high-leverage anxiety intervention. Breathing techniques: diaphragmatic breathing, box breathing, and 4-7-8 breathing activate the parasympathetic nervous system, directly reducing the physiological component of anxiety. Support groups and therapy: the social connection and shared understanding reduces the isolation that amplifies anxiety.
What is the connection between trauma, anxiety, and addiction?
Trauma, anxiety, and addiction: trauma is one of the most potent drivers of both anxiety disorders and substance use disorders. ACEs (Adverse Childhood Experiences): each additional ACE significantly increases the likelihood of both anxiety disorders and SUD in adulthood, the ACE study found dose-response relationships between childhood trauma and virtually all mental health and addiction outcomes. PTSD and SUD: PTSD and SUD co-occur at dramatically elevated rates, among people with PTSD, approximately 50% have a co-occurring SUD, among people with SUD in treatment, 30-50% have PTSD. Why: substances provide rapid, reliable relief from PTSD symptoms (hyperarousal, intrusive memories, emotional numbing), making them highly reinforcing for trauma survivors. Treatment: trauma-informed treatment addresses the trauma, not just the symptom behaviors. EMDR (Eye Movement Desensitization and Reprocessing) and CPT (Cognitive Processing Therapy) are evidence-based trauma treatments with good evidence in SUD-comorbid populations.
Does anxiety get better in sobriety?
Anxiety in sobriety, trajectory: for most people with substance-related anxiety, the trajectory is positive but non-linear. Acute phase (first 2-4 weeks): anxiety often significantly worse, withdrawal from CNS depressants (alcohol, benzodiazepines) produces severe anxiety, this is the most vulnerable period. Weeks 4-12: anxiety begins improving as neurochemistry normalizes, the post-acute withdrawal syndrome gradually resolves. Months 1-3: most people see substantial anxiety improvement compared to active use. Primary anxiety disorder: if an anxiety disorder predates substance use or persists beyond the neurochemical normalization period, it requires its own treatment (CBT, SSRIs). The key question: is the anxiety that remains in sobriety substance-induced (will continue to improve) or primary (needs independent treatment)? Timeline for assessment: most clinicians wait 4-8 weeks of abstinence before attributing anxiety to a primary disorder rather than a substance effect.
How is anxiety treated during addiction recovery?
Anxiety treatment in addiction recovery: first priority: assessment, distinguishing substance-induced anxiety (which will improve with abstinence) from primary anxiety disorder (requiring independent treatment). Acute phase: for severe withdrawal-related anxiety, medically supervised detox with appropriate medications (for alcohol/benzo withdrawal, benzodiazepines under medical supervision). Post-acute phase: CBT is the foundation of anxiety treatment in recovery, addresses both addiction and anxiety patterns. SSRIs and SNRIs: safe, effective first-line medications for primary anxiety disorders in recovery, no abuse potential, should be considered when anxiety is functionally impairing. What to avoid: benzodiazepines in people with SUD, substitute dependence risk, sedating antihistamines, alcohol or other substances. Supportive interventions: exercise, sleep hygiene, mindfulness, and social connection provide significant anxiety reduction without pharmacological risk. Recovery community: peer support reduces the social isolation that amplifies anxiety.
Can exercise help with anxiety in addiction recovery?
Exercise for anxiety in recovery: exercise is one of the most evidence-supported non-pharmacological anxiety interventions, and it aligns naturally with addiction recovery. Mechanisms: acute anxiolytic effect, 30 minutes of moderate-vigorous aerobic exercise produces clinically significant anxiety reduction for 2-4 hours afterward. Long-term: regular aerobic exercise reduces trait anxiety (baseline anxiety level) comparably to moderate pharmacotherapy in several meta-analyses. Neurobiological: exercise increases BDNF (brain-derived neurotrophic factor), promoting neuroplasticity and mood regulation, activates endorphin and endocannabinoid systems, normalizes cortisol and HPA axis reactivity, improves sleep. In recovery specifically: exercise provides a healthy dopamine system stimulation that addresses the anhedonia of early recovery, creates social opportunities, gives structure to unscheduled time, produces accomplishment and improved self-efficacy. The recommendation: 30 minutes of moderate aerobic exercise at least 5 days/week is a high-yield, low-cost anxiety management strategy that complements all other treatments.
What medications are safe for anxiety in addiction recovery?
Safe anxiety medications in recovery: SSRIs (selective serotonin reuptake inhibitors): sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), first-line for GAD, social anxiety, panic disorder, PTSD, no abuse potential, requires 4-6 weeks for full effect. SNRIs: venlafaxine (Effexor), duloxetine (Cymbalta), similar indications and safety profile. Buspirone: non-addictive anxiolytic for GAD, requires weeks to work, safe in recovery. Beta-blockers (propranolol): for situational anxiety (performance anxiety, specific phobias), not addictive, no mood effects. Hydroxyzine: antihistamine with anxiolytic effects, low abuse potential, used for acute anxiety management. Avoid: benzodiazepines (alprazolam, diazepam, clonazepam), high abuse potential in SUD populations, should generally be avoided. Gabapentin/pregabalin: have some abuse potential (particularly in opioid use disorder), use with caution. All medication decisions should be made with a psychiatrist or physician familiar with addiction medicine.